Page last updated: 2024-10-23

benzyl isothiocyanate and Animal Mammary Carcinoma

benzyl isothiocyanate has been researched along with Animal Mammary Carcinoma in 1 studies

benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma

Research Excerpts

ExcerptRelevanceReference
"Benzyl isothiocyanate (BITC) has been reported to exhibit antitumor properties in various cancer types; however, the underlying mechanisms of its action remain unclear."1.51Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β‑catenin pathway. ( Chen, J; Fan, L; Fan, W; Fu, S; Guo, L; Lin, L; Liu, H; Wang, B; Wei, H; Xie, B; Zhao, L, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xie, B1
Zhao, L1
Guo, L1
Liu, H1
Fu, S1
Fan, W1
Lin, L1
Chen, J1
Wang, B1
Fan, L1
Wei, H1

Other Studies

1 other study available for benzyl isothiocyanate and Animal Mammary Carcinoma

ArticleYear
Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β‑catenin pathway.
    Molecular medicine reports, 2019, Volume: 20, Issue:2

    Topics: Animals; Apoptosis; beta Catenin; Breast Neoplasms; Cadherins; Cell Movement; Cell Proliferation; Fe

2019